Aukera Therapeutics Secures CHF 4.5 Million in Funding and Expands Board

Marco Zingaro Europe Legal Chronicle
Tagged:

VISCHER has advised Aukera Therapeutics. Aukera Therapeutics, a preclinical-stage biotech spin-off from the University of Basel, has raised approximately CHF 4.5 million in funding and announced…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Marco Zingaro

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here